CAS: 1005504-62-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2,4-Quinazolinediamine, 5-[[1-[(2,6-dichlorophenyl)methyl]-4-piperidinyl]methoxy]- REF: AN-AG0002ASCAS: 1005504-62-0 | 98% | A consultar | Mar 21 May 24 | |
Rg3039 REF: TM-T3336CAS: 1005504-62-0 | 99.58% | 38,00 €~915,00 € | Mar 28 May 24 | |
RG3039 REF: 3D-FQB50462CAS: 1005504-62-0 | Min. 95% | A consultar | Lun 01 Jul 24 |
2,4-Quinazolinediamine, 5-[[1-[(2,6-dichlorophenyl)methyl]-4-piperidinyl]methoxy]-
CAS:1005504-62-0
Fórmula:
C21H23Cl2N5O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
432.3462
Ref: AN-AG0002AS
2mg | 97,00 € | |
5mg | 135,00 € | |
10mg | 154,00 € | |
25mg | 308,00 € | |
50mg | 626,00 € | |
100mg | A consultar | |
500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
Rg3039
CAS:1005504-62-0
Rg3039 (PF-06687859) is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular …
Fórmula:
C21H23Cl2N5O
Pureza:
99.58%
Forma y color:
Solid
Peso molecular:
432.35
Ref: TM-T3336
2mg | 38,00 € | |
5mg | 55,00 € | |
10mg | 91,00 € | |
25mg | 159,00 € | |
50mg | 253,00 € | |
100mg | 407,00 € | |
500mg | 915,00 € | |
1ml*10 (DMSO) | 62,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
RG3039
CAS:1005504-62-0
RG3039 is a novel small molecule that has been shown to have anti-leukemic activity in …
Fórmula:
C21H23Cl2N5O
Pureza:
Min. 95%
Peso molecular:
432.35 g/mol
Ref: 3D-FQB50462
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 1 de Julio de 2024